Acid Red 87

Names

[ Name ]:
Acid Red 87

[Synonym ]:
Acid Red 87
Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, sodium salt (1:2)
dawnred
bromo4d
Eosin Y,high purity,biological stain
eosin yellowish
2',4',5',7'-tetrabromofluorescein) disodium salt
RED 22
eosina
Eosin Y,Indicator grade
Bronze Bromo ES
Eosin Y water
Red A
2',4',5',7'-Tetrabromofluorescein disodium salt
D & C Red no. 21
eosine acid
2na
tetrabromofluorescein
C.I. Solvent Red 43
Bromo acid J. TS,XL,or XX
Tetrabromofluorescein Sodium Salt
Bromoeosine
EINECS 241-409-6
bromofluoresceic acid
Eosin Y,certified
bromob
Bromofluorescein
Disodium 2-(2,4,5,7-tetrabromo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate
bromots
bromoxx
Red No. 22,Eosin yellowish
MFCD00131580
bromofl
D&C Red No. 22
Eosine Yellowish-(YS)

Biological Activity

[Description]:

Eosin Y (disodium) is a soluble acid red dye molecule. Eosin Y has a wide application in organic synthesis as a photoredox catalyst[1].

[Related Catalog]:

Research Areas >> Others

Signaling Pathways >> Others >> Others

[References]

[1]. Hari DP, König B. Synthetic applications of eosin Y in photoredox catalysis. Chem Commun (Camb). 2014;50(51):6688-6699.

[2]. National Center for Biotechnology Information. PubChem Compound Summary for CID 20388, Dibromofluorescein.

Chemical & Physical Properties

[ Density]:
1.02 g/mL at 20 °C

[ Boiling Point ]:
682.3ºC at 760mmHg

[ Melting Point ]:
>300°C

[ Molecular Formula ]:
C₂₀H₆Br₄Na₂O₅

[ Molecular Weight ]:
691.854

[ Flash Point ]:
11 °C

[ Exact Mass ]:
687.674377

[ PSA ]:
81.65000

[ LogP ]:
7.59220

[ Water Solubility ]:
freely soluble

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: LM5850000

CHEMICAL NAME :: Fluorescein, 2',4',5',7'-tetrabromo-, disodium salt

CAS REGISTRY NUMBER :: 17372-87-1

LAST UPDATED :: 199806

DATA ITEMS CITED :: 12

MOLECULAR FORMULA :: C20-H8-Br4-O5.2Na

MOLECULAR WEIGHT :: 693.90

WISWESSER LINE NOTATION :: T C666 BO EVJ DE FE IR BVQ& LE MQ NE &-NA- 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 500 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 2344 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 300 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 14 gm/kg/78W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application

MUTATION DATA

TYPE OF TEST :: DNA repair

TEST SYSTEM :: Bacteria - Bacillus subtilis

DOSE/DURATION :: 2 mg/disc

REFERENCE :: TRENAF Kenkyu Nenpo--Tokyo-toritsu Eisei Kenkyusho. Annual Report of Tokyo Metropolitan Research Laboratory of Public Health. (Tokyo-toritsu Eisei Kenkyusho, 24-1, 3-chome, Hyakunin-cho, Shin-juku-ku, Tokyo 160, Japan) V.1- 1949/50- Volume(issue)/page/year: 27,153,1976 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 15,183,1977 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1450 No. of Facilities: 2601 (estimated) No. of Industries: 18 No. of Occupations: 28 No. of Employees: 24024 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1450 No. of Facilities: 4477 (estimated) No. of Industries: 20 No. of Occupations: 29 No. of Employees: 59954 (estimated) No. of Female Employees: 28062 (estimated)

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H319

[ Precautionary Statements ]:
P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
F,T,Xn,Xi

[ Risk Phrases ]:
R11

[ Safety Phrases ]:
S7-S16-S36/37-S45-S24/25-S61-S39-S26

[ RIDADR ]:
UN 1230 3/PG 2

[ WGK Germany ]:
1

[ RTECS ]:
LM5850000

[ Hazard Class ]:
3.0

[ HS Code ]:
3822001000

Customs

[ HS Code ]: 2932999099

[ Summary ]:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.

Gastroenterology 147(6) , 1405-16.e7, (2014)

New drug targets are urgently needed for the treatment of patients with pancreatic ductal adenocarcinoma (PDA). Nearly all PDAs contain oncogenic mutations in the KRAS gene. Pharmacological inhibition...

Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate.

Mater. Sci. Eng. C. Mater. Biol. Appl. 50 , 160-72, (2015)

To overcome the limited intrinsic cartilage repair, autologous chondrocyte or bone-marrow-derived mesenchymal stromal cell (BM-MSC) was implanted into cartilage defects. For this purpose suitable bioc...

Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.

Sci. Rep. 5 , 8029, (2015)

Novel molecularly targeted agents that block the development and metastasis of human brain metastatic breast cancer hold great promise for their translational value. In this study, we constructed a no...